{"id":410,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2014-10-24","marketCap":20.968257904052734,"name":"Corbus Pharmaceuticals Holdings Inc","phone":"16179630103.0","outstanding":4.420000076293945,"symbol":"CRBP","website":"https://www.corbuspharma.com/","industry":"Biotechnology"},"price":5.053875,"year":2023,"month":11,"day":3,"weekday":"Friday","title":"Analyzing the Impact of Trade Restrictions on Corbus Pharmaceuticals Holdings Inc's Supply Chain and Stock Price","date":"2023-11-03","url":"/posts/2023/11/03/CRBP","content":[{"section":"Introduction","text":"Corbus Pharmaceuticals Holdings Inc is a biopharmaceutical company that develops and commercializes drugs for the treatment of inflammatory and fibrotic diseases. As a global player in the pharmaceutical industry, the company's supply chain and stock price are susceptible to various factors, including international trade policies and restrictions."},{"section":"Corbus Pharmaceuticals' International Exposure","text":"Corbus Pharmaceuticals operates in multiple countries and relies on a global supply chain to ensure the availability and delivery of its products. The company imports raw materials and components from different regions, manufactures its drugs, and exports them to various markets. Consequently, any trade restrictions or tariffs imposed on the countries involved in Corbus Pharmaceuticals' supply chain can significantly impact its operations and financial performance."},{"section":"Impact on Supply Chain","text":"Trade restrictions and tariffs can disrupt the flow of goods and materials across borders, causing delays in the manufacturing process. If Corbus Pharmaceuticals is unable to access essential raw materials due to trade barriers, it may struggle to produce its drugs efficiently, resulting in potential supply shortages and increased costs. Additionally, increased tariffs on imported components could lead to higher production expenses, ultimately affecting the company's profitability."},{"section":"Impact on Stock Price","text":"The imposition of trade restrictions or tariffs on Corbus Pharmaceuticals' supply chain can also impact its stock price. Investors are likely to react to such developments, as changes in international trade policies can introduce uncertainties and risks to the company's future earnings and growth prospects. Adverse market reactions to trade restrictions can result in a decline in the stock price, while favorable resolutions or exemptions may have a positive effect."},{"section":"Mitigating Strategies","text":"To mitigate the potential impact of trade restrictions, Corbus Pharmaceuticals can consider diversifying its supply chain and sourcing raw materials from regions with more favorable trade policies. Collaboration with local partners and suppliers in different markets can also help reduce reliance on specific countries or regions. Additionally, active monitoring of international trade policies and proactive engagement with policymakers can allow the company to anticipate and adapt to potential changes effectively."},{"section":"Conclusion","text":"Corbus Pharmaceuticals Holdings Inc's supply chain and stock price are vulnerable to trade restrictions and tariffs imposed on the countries involved in its operations. The company must closely monitor international trade policies, diversify its supply chain, and explore partnerships to mitigate potential risks. By adopting proactive strategies and staying agile in a dynamic global trade environment, Corbus Pharmaceuticals can navigate challenges and maintain a resilient supply chain and stock price."}],"tags":["CrossUnder200","Short","Biotechnology"],"news":[{"category":"company","date":1698928479,"headline":"BRIEF-Corbus Pharmaceuticals Presents Results Of Two Pre-Clinical Studies ","id":123573478,"image":"","symbol":"CRBP","publisher":"Reuters","summary":"* CORBUS PHARMACEUTICALS PRESENTS RESULTS OF TWO PRE-CLINICAL STUDIES ON ITS ANTI-ΑVΒ8 MONOCLONAL ANTIBODY (CRB-601) AT THE 2023 SITC ANNUAL MEETING","url":"https://www.reuters.com/article/brief-corbus-pharmaceuticals-presents-re/brief-corbus-pharmaceuticals-presents-results-of-two-pre-clinical-studies-idUSTUA4D0QT3"},{"category":"company","date":1698726480,"headline":"Corbus Pharmaceuticals Holdings Inc. stock falls Tuesday, underperforms market","id":123534323,"image":"","symbol":"CRBP","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3187768951"},{"category":"company","date":1698686820,"headline":"Corbus Pharmaceuticals Holdings Inc. stock rises Monday, outperforms market","id":123527672,"image":"https://images.mktw.net/im-220105/social","symbol":"CRBP","publisher":"MarketWatch","summary":"Shares of Corbus Pharmaceuticals Holdings Inc. rallied 5.18% to $5.48 Monday, on what proved to be an all-around favorable trading session for the stock...","url":"https://www.marketwatch.com/data-news/corbus-pharmaceuticals-holdings-inc-stock-rises-monday-outperforms-market-efeb54ee-730f6dc174ea"},{"category":"company","date":1698640440,"headline":"Bullish Monday For Marijuana Stocks - EVIO, Rocky Mountain High Among Top Gainers","id":123506893,"image":"","symbol":"CRBP","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3185752286"},{"category":"company","date":1698427560,"headline":"Corbus Pharmaceuticals Holdings Inc. stock outperforms market on strong trading day","id":123485170,"image":"https://images.mktw.net/im-220105/social","symbol":"CRBP","publisher":"MarketWatch","summary":"Shares of Corbus Pharmaceuticals Holdings Inc. advanced 1.56% to $5.21 Friday, on what proved to be an all-around mixed trading session for the stock market,...","url":"https://www.marketwatch.com/data-news/corbus-pharmaceuticals-holdings-inc-stock-outperforms-market-on-strong-trading-day-6894f00c-a4f0a186a35e"},{"category":"company","date":1698341160,"headline":"Corbus Pharmaceuticals Holdings Inc. stock falls Thursday, underperforms market","id":123485171,"image":"https://images.mktw.net/im-220105/social","symbol":"CRBP","publisher":"MarketWatch","summary":"Shares of Corbus Pharmaceuticals Holdings Inc. plunged 10.31% to $5.13 Thursday, on what proved to be an all-around rough trading session for the stock...","url":"https://www.marketwatch.com/data-news/corbus-pharmaceuticals-holdings-inc-stock-falls-thursday-underperforms-market-1f93c09a-545eda3e571e"},{"category":"company","date":1698294960,"headline":"Marijuana Stock Movers For October 26, 2023","id":123432431,"image":"","symbol":"CRBP","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179995546"},{"category":"company","date":1698254760,"headline":"Corbus Pharmaceuticals Holdings Inc. stock outperforms market despite losses on the day","id":123485172,"image":"https://images.mktw.net/im-220105/social","symbol":"CRBP","publisher":"MarketWatch","summary":"Shares of Corbus Pharmaceuticals Holdings Inc. shed 1.72% to $5.72 Wednesday, on what proved to be an all-around grim trading session for the stock market,...","url":"https://www.marketwatch.com/data-news/corbus-pharmaceuticals-holdings-inc-stock-outperforms-market-despite-losses-on-the-day-869a9120-f67d68d168c6"},{"category":"company","date":1698168360,"headline":"Corbus Pharmaceuticals Holdings Inc. stock rises Tuesday, still underperforms market","id":123485173,"image":"https://images.mktw.net/im-220105/social","symbol":"CRBP","publisher":"MarketWatch","summary":"Shares of Corbus Pharmaceuticals Holdings Inc. inched 0.52% higher to $5.82 Tuesday, on what proved to be an all-around favorable trading session for the...","url":"https://www.marketwatch.com/data-news/corbus-pharmaceuticals-holdings-inc-stock-rises-tuesday-still-underperforms-market-f19da1b6-b288d844743e"},{"category":"company","date":1698081960,"headline":"Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors","id":123349267,"image":"https://images.mktw.net/im-220105/social","symbol":"CRBP","publisher":"MarketWatch","summary":"Shares of Corbus Pharmaceuticals Holdings Inc. slipped 3.50% to $5.79 Monday, on what proved to be an all-around mixed trading session for the stock market,...","url":"https://www.marketwatch.com/data-news/corbus-pharmaceuticals-holdings-inc-stock-underperforms-monday-when-compared-to-competitors-6ff93415-ffbbe5eb2698"},{"category":"company","date":1698035580,"headline":"Cannabis Stock Gainers And Losers From October 23, 2023","id":123346886,"image":"","symbol":"CRBP","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3173998317"},{"category":"company","date":1697822760,"headline":"Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors","id":123330767,"image":"https://images.mktw.net/im-220105/social","symbol":"CRBP","publisher":"MarketWatch","summary":"Shares of Corbus Pharmaceuticals Holdings Inc. slumped 0.33% to $6.00 Friday, on what proved to be an all-around rough trading session for the stock market,...","url":"https://www.marketwatch.com/data-news/corbus-pharmaceuticals-holdings-inc-stock-underperforms-friday-when-compared-to-competitors-f6f065af-d2bb22791692"},{"category":"company","date":1697776380,"headline":"Bearish Friday For Marijuana Stocks - MPX International, Maple Leaf Green World Among Top Gainers","id":123297432,"image":"","symbol":"CRBP","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3170492209"}]}